Summary
Marco Egbring is a Chief Medical Officer and clinical pharmacologist with 12 years of experience blending precision medicine, data science, and entrepreneurship to improve drug safety and patient outcomes. He has led health-tech initiatives from founding epha.health—bringing pharmacogenetics and AI into clinical workflows—to directing data science collaborations with Helsana that transformed medication management at scale. His background spans frontline clinical roles and technical leadership, including architecting web-based medication records and producing innovative patient education media. Marco pairs an MD and board certification in Clinical Pharmacology with an MBA, enabling him to translate complex biomedical science into usable digital products and partnerships. Known for prioritizing both efficacy and safety, he focuses on algorithm-driven decisions grounded in clinical reality. Based in Zurich, he combines deep clinical credibility with a proven track record of shipping practical, safety-focused health technology.
12 years of coding experience
9 years of employment as a software developer
Board Certification, Clinical Pharmacology and Toxicology, Board Certification, Clinical Pharmacology and Toxicology at University Hospital Zurich
Graduation, Graduation at Gymnasium Ottobrunn
Master of Business Administration - MBA, Master of Business Administration - MBA at Universität St. Gallen-Hochschule für Wirtschafts-, Rechts- und Sozialwissenschaften
Doctor of Medicine - MD, Quality assurance of radiographs via the Internet, Doctor of Medicine - MD, Quality assurance of radiographs via the Internet at Leipzig University
Master's degree, Medicine, Master's degree, Medicine at University of Leipzig
Graduation, Graduation at Romulus Central Highschool